Copyright: ©Author(s) 2026.
World J Transl Med. Sep 28, 2026; 12(3): 123615
Published online Sep 28, 2026. doi: 10.5528/wjtm.123615
Published online Sep 28, 2026. doi: 10.5528/wjtm.123615
Table 2 Association between cardio-ankle vascular index and prognosis in populations with a high prevalence of diabetes
| Ref. | Population | Diabetes proportion | Outcome assessed | Follow-up duration | Summary |
| Bäck et al[22] | Outpatient clinics for prevention, check-up, and/or monitoring of CV risk factors | 23%-24% DM | CV morbidity and mortality | 3.82 years (median) | The optimal CAVI thresholds for predicting outcomes differed among age groups, with thresholds of 9.25 for CV morbidity and mortality and 9.95 for all-cause mortality in subjects aged ≥ 60 years |
| Suwannasom et al[47] | Patients with diabetes, aged 40-69 years | 100% DM | All-cause death and CV events | 59.9 months (median) | CAVI, whether analyzed as a continuous variable or by risk group, did not predict the primary outcomes |
| Miyoshi et al[19] | Patients with CV risk | ≥ 72% DM | CV death and CV events | 4.9 years (median) | A CAVI > 9.5 was significantly associated with higher risks of cardiovascular death and nonfatal stroke (crude HR = 3.83, 95%CI: 1.28-11.40; crude HR = 2.07, 95%CI: 1.07-3.91) |
| Kario et al[20] | Patients with CV risk | 32.4% DM | CV death and CV events | 5.0 years (median) | The group with CAVI > 10.0 had the highest risk of a cardiovascular event (HR = 1.74, 95%CI: 1.08-2.81) |
- Citation: Kabutoya T. Arterial stiffness and endothelial dysfunction in diabetes mellitus. World J Transl Med 2026; 12(3): 123615
- URL: https://www.wjgnet.com/2220-6132/full/v12/i3/123615.htm
- DOI: https://dx.doi.org/10.5528/wjtm.123615